Brian Scott

1.2k total citations
24 papers, 1.0k citations indexed

About

Brian Scott is a scholar working on Pharmacology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Brian Scott has authored 24 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 8 papers in Molecular Biology and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Brian Scott's work include Cannabis and Cannabinoid Research (9 papers), Alcohol Consumption and Health Effects (5 papers) and Pharmacological Receptor Mechanisms and Effects (3 papers). Brian Scott is often cited by papers focused on Cannabis and Cannabinoid Research (9 papers), Alcohol Consumption and Health Effects (5 papers) and Pharmacological Receptor Mechanisms and Effects (3 papers). Brian Scott collaborates with scholars based in United States, United Kingdom and Australia. Brian Scott's co-authors include Bin Jiang, Paul S. Watson, Sandra R. Chaplan, J. Guy Breitenbucher, Michael Webb, John N. Wood, Nigel A. Calcutt, Stephen B. McMahon, Z. David Luo and Armen N. Akopian and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Brian Scott

24 papers receiving 987 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brian Scott United States	15	401	337	244	166	160	24	1.0k
Stefania Baraldi Italy	18	370 0.9×	398 1.2×	116 0.5×	67 0.4×	103 0.6×	29	906
Carol S. Surowy United States	27	231 0.6×	859 2.5×	239 1.0×	263 1.6×	328 2.0×	51	1.6k
Pier Vincenzo Plazzi Italy	22	585 1.5×	533 1.6×	456 1.9×	64 0.4×	279 1.7×	50	1.5k
Małgorzata Zygmunt Poland	18	236 0.6×	279 0.8×	103 0.4×	84 0.5×	113 0.7×	64	814
Wolfram Hänsel Germany	15	390 1.0×	859 2.5×	123 0.5×	166 1.0×	245 1.5×	45	1.5k
Uwe Grether Switzerland	21	343 0.9×	715 2.1×	377 1.5×	83 0.5×	225 1.4×	67	1.3k
Shigenori Ohkawa Japan	18	337 0.8×	295 0.9×	122 0.5×	190 1.1×	144 0.9×	31	1.3k
Jörge Beleta Spain	22	274 0.7×	579 1.7×	189 0.8×	393 2.4×	176 1.1×	50	1.3k
Hayato Fukuda Japan	18	322 0.8×	213 0.6×	66 0.3×	64 0.4×	63 0.4×	61	848
J. Guy Breitenbucher United States	26	663 1.7×	833 2.5×	763 3.1×	210 1.3×	322 2.0×	50	2.1k

Countries citing papers authored by Brian Scott

Since Specialization

Citations

This map shows the geographic impact of Brian Scott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Scott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Scott more than expected).

Fields of papers citing papers by Brian Scott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Scott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Scott. The network helps show where Brian Scott may publish in the future.

Co-authorship network of co-authors of Brian Scott

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Scott. A scholar is included among the top collaborators of Brian Scott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Scott. Brian Scott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Coe, Kevin J., Mark Feinstein, J. William Higgins, et al.. (2022). Characterization of JNJ-2482272 [4-(4-Methyl-2-(4-(Trifluoromethyl)Phenyl)Thiazole-5-yl) Pyrimidine-2-Amine] As a Strong Aryl Hydrocarbon Receptor Activator in Rat and Human. Drug Metabolism and Disposition. 50(8). 1064–1076. 2 indexed citations

Steeneck, Christoph, Christian Gege, Olaf Kinzel, et al.. (2020). Discovery and optimization of new oxadiazole substituted thiazole RORγt inverse agonists through a bioisosteric amide replacement approach. Bioorganic & Medicinal Chemistry Letters. 30(12). 127174–127174. 14 indexed citations

Gege, Christian, M. Albers, Olaf Kinzel, et al.. (2020). Optimization and biological evaluation of thiazole-bis-amide inverse agonists of RORγt. Bioorganic & Medicinal Chemistry Letters. 30(12). 127205–127205. 10 indexed citations

Keith, John M., W. M. Jones, Mark Seierstad, et al.. (2020). Heteroarylureas with fused bicyclic diamine cores as inhibitors of fatty acid amide hydrolase. Bioorganic & Medicinal Chemistry Letters. 30(20). 127463–127463. 4 indexed citations

Chrovian, Christa C., Daniel J. Pippel, Brian Lord, et al.. (2020). Design, Synthesis, and Preclinical Evaluation of 3-Methyl-6-(5-thiophenyl)-1,3-dihydro-imidazo[4,5-b]pyridin-2-ones as Selective GluN2B Negative Allosteric Modulators for the Treatment of Mood Disorders. Journal of Medicinal Chemistry. 63(17). 9181–9196. 6 indexed citations

Venkatesan, Hariharan, Maxwell D. Cummings, M. Albers, et al.. (2019). 3-Substituted Quinolines as RORγt Inverse Agonists. Bioorganic & Medicinal Chemistry Letters. 29(12). 1463–1470. 9 indexed citations

Chrovian, Christa C., Christine F. Gelin, Xiaohu Deng, et al.. (2017). A Dipolar Cycloaddition Reaction To Access 6-Methyl-4,5,6,7-tetrahydro-1H-[1,2,3]triazolo[4,5-c]pyridines Enables the Discovery Synthesis and Preclinical Profiling of a P2X7 Antagonist Clinical Candidate. Journal of Medicinal Chemistry. 61(1). 207–223. 60 indexed citations

Keith, John M., Mark S. Tichenor, Richard L. Apodaca, et al.. (2016). The SAR of brain penetration for a series of heteroaryl urea FAAH inhibitors. Bioorganic & Medicinal Chemistry Letters. 26(13). 3109–3114. 11 indexed citations

Swanson, Devin M., Brad M. Savall, Kevin J. Coe, et al.. (2016). Identification of (R)-(2-Chloro-3-(trifluoromethyl)phenyl)(1-(5-fluoropyridin-2-yl)-4-methyl-6,7-dihydro-1H-imidazo[4,5-c]pyridin-5(4H)-yl)methanone (JNJ 54166060), a Small Molecule Antagonist of the P2X7 receptor. Journal of Medicinal Chemistry. 59(18). 8535–8548. 30 indexed citations

10.

Edwards, Wilson B., Wai‐Ping Fung‐Leung, Chichi Huang, et al.. (2014). Targeting the Ion Channel Kv1.3 with Scorpion Venom Peptides Engineered for Potency, Selectivity, and Half-life. Journal of Biological Chemistry. 289(33). 22704–22714. 26 indexed citations

11.

Keith, John M., W. M. Jones, Mark Seierstad, et al.. (2014). Heteroarylureas with spirocyclic diamine cores as inhibitors of fatty acid amide hydrolase. Bioorganic & Medicinal Chemistry Letters. 24(3). 737–741. 24 indexed citations

12.

Keith, John M., Natalie A. Hawryluk, Richard L. Apodaca, et al.. (2014). 1-Aryl-2-((6-aryl)pyrimidin-4-yl)amino)ethanols as competitive inhibitors of fatty acid amide hydrolase. Bioorganic & Medicinal Chemistry Letters. 24(5). 1280–1284. 11 indexed citations

13.

Hawryluk, Natalie A., Alec D. Lebsack, Michael D. Hack, et al.. (2010). Discovery and synthesis of 6,7,8,9-tetrahydro-5H-pyrimido-[4,5-d]azepines as novel TRPV1 antagonists. Bioorganic & Medicinal Chemistry Letters. 20(23). 7137–7141. 7 indexed citations

14.

Karbarz, Mark J., Lin Luo, Leon Chang, et al.. (2008). Biochemical and Biological Properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a Mechanism-Based Inhibitor of Fatty Acid Amide Hydrolase. Anesthesia & Analgesia. 108(1). 316–329. 61 indexed citations

15.

Keith, John M., Richard L. Apodaca, Wei Xiao, et al.. (2008). Thiadiazolopiperazinyl ureas as inhibitors of fatty acid amide hydrolase. Bioorganic & Medicinal Chemistry Letters. 18(17). 4838–4843. 76 indexed citations

16.

Seierstad, Mark, Richard L. Apodaca, Sean M. Brown, et al.. (2008). Novel ketooxazole based inhibitors of fatty acid amide hydrolase (FAAH). Bioorganic & Medicinal Chemistry Letters. 18(6). 2109–2113. 25 indexed citations

17.

Lebsack, Alec D., Michael D. Hack, Wei Xiao, et al.. (2008). Identification and synthesis of 2,7-diamino-thiazolo[5,4-d]pyrimidine derivatives as TRPV1 antagonists. Bioorganic & Medicinal Chemistry Letters. 19(1). 40–46. 18 indexed citations

18.

Bhattacharya, Anindya, Brian Scott, Nadia Nasser, et al.. (2007). Pharmacology and Antitussive Efficacy of 4-(3-Trifluoromethyl-pyridin-2-yl)-piperazine-1-carboxylic Acid (5-Trifluoromethyl-pyridin-2-yl)-amide (JNJ17203212), a Transient Receptor Potential Vanilloid 1 Antagonist in Guinea Pigs. Journal of Pharmacology and Experimental Therapeutics. 323(2). 665–674. 62 indexed citations

19.

Briggs, M., et al.. (2002). Towards novel biolabels: synthesis of a tagged highly fluorescent Schiff-base aluminium complex. Tetrahedron Letters. 43(29). 5169–5171. 21 indexed citations

20.

Okuse, Kenji, Sandra R. Chaplan, Stephen B. McMahon, et al.. (1997). Regulation of Expression of the Sensory Neuron-Specific Sodium Channel SNS in Inflammatory and Neuropathic Pain. Molecular and Cellular Neuroscience. 10(3-4). 196–207. 135 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact